Ogilvy-Carter Scale in Aneurysmal Subarachnoid Hemorrhage
The Ogilvy-Carter scale is a combined grading system that integrates both clinical and radiological parameters to predict outcomes in aneurysmal subarachnoid hemorrhage (aSAH), though it is not independently predictive of mortality and should not be used as your primary grading tool.
What the Scale Does
The Ogilvy-Carter scale combines clinical severity assessment with radiological findings to stratify patients with aSAH. While it effectively distinguishes between survivors and nonsurvivors, recent evidence demonstrates it lacks independent predictive value for mortality when compared to traditional clinical scales 1.
Clinical Performance and Limitations
In a 2025 multicenter study of 451 aSAH patients:
- Nonsurvivors had significantly higher Ogilvy-Carter scores compared to survivors (p < 0.001) 1
- However, the scale was NOT an independent predictor of mortality in multivariable analysis 1
- The WFNS scale emerged as the most reliable mortality predictor (AUC 0.878), followed by modified Fisher scale and Hunt-Hess scale 1
Recommended Grading Approach
Use the WFNS scale as your primary clinical grading tool for aSAH patients, as recommended by the 2023 AHA/ASA guidelines 2. The guidelines specifically recommend:
- Hunt and Hess (HH) grade OR World Federation of Neurosurgical Societies (WFNS) grade to determine initial clinical severity and predict outcome (Class I, Level B-NR) 2
- These traditional clinical scales have stronger evidence for outcome prediction than combined systems like Ogilvy-Carter
Practical Application
When evaluating aSAH patients:
- Primary assessment: Use WFNS or Hunt-Hess grading immediately
- Radiological assessment: Add modified Fisher scale for hemorrhage burden
- Combined systems (like Ogilvy-Carter or VASOGRADE): May provide additional context but should not replace traditional clinical grading
Common Pitfall to Avoid
Do not rely solely on combined grading systems like Ogilvy-Carter for prognostication or treatment decisions. While these scales incorporate multiple parameters, they have not demonstrated superior predictive ability compared to simpler, validated clinical scales that are specifically endorsed by major guidelines 2, 1.